Hysingla ER and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Hysingla ER and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: n.a.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hysingla ER-Moxifloxacin
- Hysingla ER-Moxifloxacin (Systemic)
- Hysingla ER-Moxifloxacin Hydrochloride
- Hysingla ER-Moxifloxacin Injection
- Hysingla ER-Moxifloxacin Intravenous
- Hysingla ER-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Hyskon high molecular weight
- Moxetumomab pasudotox-tdfk Intravenous-Hytone
- Moxetumomab pasudotox-tdfk Intravenous-Hytrin
- Moxetumomab pasudotox-tdfk Intravenous-Hytrin capsules
- Moxetumomab pasudotox-tdfk Intravenous-Hyzaar
- Moxetumomab pasudotox-tdfk Intravenous-Hyzine